Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taebo Sim

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of a Series of 5,11-Dihydro-6<i>H</i>-benzo[<i>e</i>]pyrimido[5,4-<i>b</i>][1,4]diazepin-6-ones as Selective PI3K-δ/γ InhibitorsFleur M Ferguson, Jing Ni, Tinghu Zhang, et al.
The Journal of Biological Chemistry|August 15, 2009
N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitorYongmun Choi, Markus A Seeliger, Shoghag B Panjarian, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2018
Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitorsMin Jung Choi, Eun Joo Roh, Wooyoung Hur, et al.
Chemical & Pharmaceutical Bulletin|July 2, 2013
Novel quinolinylaminoisoquinoline bioisosteres of sorafenib as selective RAF1 kinase inhibitors: design, synthesis, and antiproliferative activity against melanoma cell lineHye Jung Cho, Mohammed Ibrahim El-Gamal, Chang-Hyun Oh, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell lineHee Jin Kim, Hye Jung Cho, Hwan Kim, et al.
The Journal of Biological Chemistry|January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu, Jinhua Wang, Seong A Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung CancerCurtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Synthesis and biological evaluation of new pyrazol-4-ylpyrimidine derivatives as potential ROS1 kinase inhibitorsAhmed Z Abdelazem, Mohammad M Al-Sanea, Byung Sun Park, et al.
Journal of Medicinal Chemistry|September 13, 2019
Identification of a Unique Resorcylic Acid Lactone Derivative That Targets Both Lymphangiogenesis and AngiogenesisYoungsun Han, Sandip Sengupta, Byung Joo Lee, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of a Series of 5,11-Dihydro-6<i>H</i>-benzo[<i>e</i>]pyrimido[5,4-<i>b</i>][1,4]diazepin-6-ones as Selective PI3K-δ/γ InhibitorsFleur M Ferguson, Jing Ni, Tinghu Zhang, et al.
The Journal of Biological Chemistry|August 15, 2009
N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitorYongmun Choi, Markus A Seeliger, Shoghag B Panjarian, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2018
Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitorsMin Jung Choi, Eun Joo Roh, Wooyoung Hur, et al.
Chemical & Pharmaceutical Bulletin|July 2, 2013
Novel quinolinylaminoisoquinoline bioisosteres of sorafenib as selective RAF1 kinase inhibitors: design, synthesis, and antiproliferative activity against melanoma cell lineHye Jung Cho, Mohammed Ibrahim El-Gamal, Chang-Hyun Oh, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell lineHee Jin Kim, Hye Jung Cho, Hwan Kim, et al.
The Journal of Biological Chemistry|January 20, 2009
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1Carson C Thoreen, Seong A Kang, Jae Won Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2011
Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu, Jinhua Wang, Seong A Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung CancerCurtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Synthesis and biological evaluation of new pyrazol-4-ylpyrimidine derivatives as potential ROS1 kinase inhibitorsAhmed Z Abdelazem, Mohammad M Al-Sanea, Byung Sun Park, et al.
Journal of Medicinal Chemistry|September 13, 2019
Identification of a Unique Resorcylic Acid Lactone Derivative That Targets Both Lymphangiogenesis and AngiogenesisYoungsun Han, Sandip Sengupta, Byung Joo Lee, et al.
Pageof 13